Loading...

J&J: Potential HIV vaccine falls short in mid-stage study


J&J: Potential HIV vaccine falls short in mid-stage study



A potential HIV vaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the drugmaker said Tuesday.

Health Tips 1465334789782777416

Post a Comment

emo-but-icon

Home item